|
1
|
Winters S, Martin C, Murphy D and Shokar
NK: Breast cancer epidemiology, prevention, and screening. Prog Mol
Biol Transl Sci. 151:1–32. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Fraser VJ, Nickel KB, Fox IK, Margenthaler
JA and Olsen MA: The epidemiology and outcomes of breast cancer
surgery. Trans Am Clin Climatol Assoc. 127:46–58. 2016.PubMed/NCBI
|
|
3
|
Rojas K and Stuckey A: Breast cancer
epidemiology and risk factors. Clin Obstet Gynecol. 59:651–672.
2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sung H, Ren J, Li J, Pfeiffer RM, Wang Y,
Guida JL, Fang Y, Shi J, Zhang K and Li N: Breast cancer risk
factors and mammographic density among high-risk women in urban
China. NPJ Breast Cancer. 4(3)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Li T, Tang L, Gandomkar Z, Heard R,
Mello-Thoms C, Shao Z and Brennan P: Mammographic density and other
risk factors for breast cancer among women in China. Breast J.
24:426–428. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zuo TT, Zheng RS, Zeng HM, Zhang SW and
Chen WQ: Female breast cancer incidence and mortality in China,
2013. Thorac Cancer. 8:214–218. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lee EY and Muller WJ: Oncogenes and tumor
suppressor genes. Cold Spring Harb Perspect Biol.
2(a003236)2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang LH, Wu CF, Rajasekaran N and Shin YK:
Loss of tumor suppressor gene function in human cancer: An
overview. Cell Physiol Biochem. 51:2647–2693. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Asp N, Kvalvaag A, Sandvig K and Pust S:
Regulation of ErbB2 localization and function in breast cancer
cells by ERM proteins. Oncotarget. 7:25443–25460. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Pokharel D, Padula MP, Lu JF, Jaiswal R,
Djordjevic SP and Bebawy M: The role of CD44 and ERM proteins in
expression and functionality of P-glycoprotein in breast cancer
cells. Molecules. 21(290)2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Clucas J and Valderrama F: ERM proteins in
cancer progression. J Cell Sci. 127:267–275. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Montt-Guevara MM, Shortrede JE, Giretti
MS, Giannini A, Mannella P, Russo E, Genazzani AD and Simoncini T:
Androgens regulate T47D cells motility and invasion through actin
cytoskeleton remodeling. Front Endocrinol (Lausanne).
7(136)2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Fernando H, Martin TA, Douglas-Jones A,
Kynaston HG, Mansel RE and Jiang WG: Expression of the ERM family
members (ezrin, radixin and moesin) in breast cancer. Exp Ther Med.
1:153–160. 2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tsai MM, Wang CS, Tsai CY, Chen CY, Chi
HC, Tseng YH, Chung PJ, Lin YH, Chung IH, Chen CY and Lin KH:
MicroRNA-196a/-196b promote cell metastasis via negative regulation
of radixin in human gastric cancer. Cancer Lett. 351:222–231.
2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhu YW, Yan JK, Li JJ, Ou YM and Yang Q:
Knockdown of radixin suppresses gastric cancer metastasis in vitro
by up-regulation of E-Cadherin via NF-κB/Snail pathway. Cell
Physiol Biochem. 39:2509–2521. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
He J, Zhao J, Zhu W, Qi D, Wang L, Sun J,
Wang B, Ma X, Dai Q and Yu X: MicroRNA biogenesis pathway genes
polymorphisms and cancer risk: A systematic review and
meta-analysis. PeerJ. 4(e2706)2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shrestha S, Hsu SD, Huang WY, Huang HY,
Chen W, Weng SL and Huang HD: A systematic review of microRNA
expression profiling studies in human gastric cancer. Cancer Med.
3:878–888. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Catto JW, Alcaraz A, Bjartell AS, De Vere
White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L,
Schlomm T and Visakorpi T: MicroRNA in prostate, bladder, and
kidney cancer: A systematic review. Eur Urol. 59:671–681.
2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li X, Abdel-Mageed AB, Mondal D and Kandil
E: MicroRNA expression profiles in differentiated thyroid cancer, a
review. Int J Clin Exp Med. 6:74–80. 2013.PubMed/NCBI
|
|
20
|
Janiak M, Paskal W, Rak B, Garbicz F,
Jarema R, Sikora K and Włodarski P: TIMP4 expression is regulated
by miR-200b-3p in prostate cancer cells. APMIS. 125:101–105.
2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xiao P, Liu W and Zhou H: miR-200b
inhibits migration and invasion in non-small cell lung cancer cells
via targeting FSCN1. Mol Med Rep. 14:1835–1840. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zeng F, Xue M, Xiao T, Li Y, Xiao S, Jiang
B and Ren C: MiR-200b promotes the cell proliferation and
metastasis of cervical cancer by inhibiting FOXG1. Biomed
Pharmacother. 79:294–301. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Arpin M, Chirivino D, Naba A and
Zwaenepoel I: Emerging role for ERM proteins in cell adhesion and
migration. Cell Adh Migr. 5:199–206. 2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Fehon RG, McClatchey AI and Bretscher A:
Organizing the cell cortex: The role of ERM proteins. Nat Rev Mol
Cell Biol. 11:276–287. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Ivetic A and Ridley AJ:
Ezrin/radixin/moesin proteins and Rho GTPase signalling in
leucocytes. Immunology. 112:165–176. 2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bartholow TL, Chandran UR, Becich MJ and
Parwani AV: Immunohistochemical staining of radixin and moesin in
prostatic adenocarcinoma. BMC Clin Pathol. 11(1)2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chen SD, Song MM, Zhong ZQ, Li N, Wang PL,
Cheng S, Bai RX and Yuan H: Knockdown of radixin by RNA
interference suppresses the growth of human pancreatic cancer cells
in vitro and in vivo. Asian Pac J Cancer Prev. 13:753–759.
2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hua D, Ding D, Han X, Zhang W, Zhao N,
Foltz G, Lan Q, Huang Q and Lin B: Human miR-31 targets radixin and
inhibits migration and invasion of glioma cells. Oncol Rep.
27:700–706. 2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Qin JJ, Wang JM, Du J, Zeng C, Han W, Li
ZD, Xie J and Li GL: Radixin knockdown by RNA interference
suppresses human glioblastoma cell growth in vitro and in vivo.
Asian Pac J Cancer Prev. 15:9805–9812. 2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li D, Wang H, Song H, Xu H, Zhao B, Wu C,
Hu J, Wu T, Xie D, Zhao J, et al: The microRNAs miR-200b-3p and
miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and
motility of breast cancer cells. Oncotarget. 8:85276–85289.
2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yang X, Hu Q, Hu LX, Lin XR, Liu JQ, Lin
X, Dinglin XX, Zeng JY, Hu H, Luo ML and Yao HR: miR-200b regulates
epithelial-mesenchymal transition of chemo-resistant breast cancer
cells by targeting FN1. Discov Med. 24:75–85. 2017.PubMed/NCBI
|
|
33
|
Yao Y, Hu J, Shen Z, Yao R, Liu S, Li Y,
Cong H, Wang X, Qiu W and Yue L: MiR-200b expression in breast
cancer: A prognostic marker and act on cell proliferation and
apoptosis by targeting Sp1. J Cell Mol Med. 19:760–769.
2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hong H, Yu HZ, Yuan JF, Guo C, Cao H, Li W
and Xiao C: MicroRNA-200b impacts breast cancer cell migration and
invasion by regulating ezrin-radixin-moesin. Med Sci Monit.
22:1946–1952. 2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Humphries B, Wang Z, Li Y, Jhan JR, Jiang
Y and Yang C: ARHGAP18 downregulation by miR-200b suppresses
metastasis of triple-negative breast cancer by enhancing activation
of RhoA. Cancer Res. 77:4051–4064. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ye F, Tang H, Liu Q and Xie X, Wu M, Liu
X, Chen B and Xie X: miR-200b as a prognostic factor in breast
cancer targets multiple members of RAB family. J Transl Med.
12(17)2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zheng Q, Cui X, Zhang D, Yang Y, Yan X,
Liu M, Niang B, Aziz F, Liu S, Yan Q and Liu J: miR-200b inhibits
proliferation and metastasis of breast cancer by targeting
fucosyltransferase IV and α1,3-fucosylated glycans. Oncogenesis.
6(e358)2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Valastyan S, Benaich N, Chang A, Reinhardt
F and Weinberg RA: Concomitant suppression of three target genes
can explain the impact of a microRNA on metastasis. Genes Dev.
23:2592–2597. 2009.PubMed/NCBI View Article : Google Scholar
|
